Cell Reprogramming & Therapeutics develops cell reprogramming technologies to treat central nervous system diseases.
Cell Reprogramming & Therapeutics develops cell reprogramming technologies to treat central nervous system diseases. The company was founded in 2013 and is based in Wauwatosa, Wisconsin.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 6, 2018 | Grant | $294.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |